Today: 16 May 2026
Kruk’s 9% plunge puts Warsaw Stock Exchange in focus: what to watch for WIG20 this week
22 February 2026
1 min read

Kruk’s 9% plunge puts Warsaw Stock Exchange in focus: what to watch for WIG20 this week

WARSAW, Feb 22, 2026, 09:44 CET — The market is shut.

  • Kruk tumbled 9.26% on Friday, posting the steepest loss in the WIG20. The index itself edged down 0.04%.
  • Early in the week brings Poland’s retail sales and labor market data, a pair investors are eyeing for new catalysts.
  • Kruk will release its complete unaudited fourth-quarter report on Feb. 26, following its earlier preliminary estimates.

On Friday, Kruk sank 9.26%, posting the sharpest loss on Warsaw’s WIG20 blue chip index and putting pressure on sentiment going into the new week. The WIG20 itself slipped 0.04% to finish at 3,383.82 points.

The market, lacking a clear driver, ended almost unchanged. “The WIG20 finished the week in patterns that force investors to wait for a turning point,” BOŚ Brokerage analyst Adam Stańczak said in a post-session note Friday. Dom Maklerski Banku Ochrony Środowiska

The calendar doesn’t lack for action. Monday brings January retail sales from Statistics Poland. On Tuesday, the agency lines up its fourth-quarter 2025 labour force survey, and also rolls out a wide-ranging “socio-economic situation” update for January. Statistics Poland

Kruk has its next key date on the calendar. The company reported a preliminary consolidated net profit for the fourth quarter of 208 million zlotys, and pegged estimated cash EBITDA at 658 million zlotys. Kruk also put its estimated net debt to cash EBITDA ratio at 2.6, adding that these figures “are subject to change.” Kruk

Friday’s drop in the stock put investors on alert for spillover into other rate-sensitive sectors, notably lenders and consumer stocks that tend to react sharply to unexpected domestic data.

The pain was clear in the tape: energy stocks and consumer plays dragged, but a handful of big resource and construction names kept the index from sliding further.

On top of the regular data releases, traders are eyeing the central bank’s figures for any clues about liquidity and credit in the system. The National Bank of Poland plans to post its broad money (M3) numbers on Monday, its calendar shows.

External risk remains a factor for Warsaw, despite domestic news setting the pace. On Friday, a survey indicated euro zone business activity picked up in February. The composite purchasing managers’ index (PMI) climbed to 51.9—signaling expansion as manufacturing moved back into growth territory.

Still, the week isn’t locked in. Disappointing retail sales, shaky labour figures, or a sudden “risk-off” mood out of Europe could leave the WIG20 stuck where it’s been—and hit stocks that have outpaced their fundamentals.

Stock Market Today

  • W. R. Berkley (WRB) Shows 45.9% Undervaluation Despite Recent Price Stability
    May 15, 2026, 7:55 PM EDT. W. R. Berkley (WRB) stock has shown limited movement recently with a 1.2% gain over 7 days and a 4.2% decline year-to-date. Analysts use valuation methods like Excess Returns, which estimates intrinsic value by calculating profits above shareholder required returns. With an intrinsic value estimate of $122.79 against a current price near $66.45, the stock appears 45.9% undervalued. The insurer's steady underwriting profile and capital discipline contrast with sector concerns on insurance pricing and interest rate sensitivity. WRB currently scores 2 out of 6 on valuation metrics, highlighting potential but raising caution.

Latest articles

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Western Digital stock: 3 things to know before Monday after Sandisk stake-sale move
Next Story

Western Digital stock: 3 things to know before Monday after Sandisk stake-sale move

Go toTop